Literature DB >> 26001434

Left ventricular remodeling and fibrosis: Sex differences and relationship with diastolic function in hypertrophic cardiomyopathy.

You-Zhou Chen1, Shu-Bin Qiao2, Feng-Huan Hu1, Jian-Song Yuan1, Wei-Xian Yang1, Jin-Gang Cui1, Yan Zhang3, Chang-Lin Zhang1.   

Abstract

OBJECTIVES: We investigated sex differences in left ventricular (LV) remodeling and fibrosis and their relationship with LV diastolic dysfunction by cardiovascular magnetic resonance (CMR).
METHODS: CMR imaging was performed simultaneously in 152 age-matched patients (76 men, 76 women; mean age: 49±9 years) without LV systolic dysfunction. LV remodeling index (LVRI) was calculated as the ratio of LV mass and end-diastolic volume. Diastolic function indexes including peak filling rate (PFR) and time to PFR (tPFR) were evaluated. Extent of late gadolinium enhancement (LGE) was measured.
RESULTS: LVRI and extent of LGE were greater in women compared with men (1.48±0.22 vs. 1.36±0.28g/ml; 13.15±2.48 vs. 11.35±2.34g, respectively, both P<0.001). Women had lower PFR and higher tPFR (both P<0.001) than men. LVRI and the extent of LGE showed significant relationships with parameters of diastolic function in both sex. In a multivariate analysis, LVRI remained a strong independent predictor of PFR and TPFR in women (β=-0.272, P=0.032; β=0.348, P=0.016, respectively), and in men (β=-0.374, P<0.001; β=0.660, P<0.001, respectively). Furthermore, the extent of LGE also remained an independent predictor of PFR in women (β=-0.283, P=0.033) and men (β=-0.492, P<0.001).
CONCLUSIONS: There are prominent sex differences in LV remodeling and myocardial fibrosis. We suggest that the effects of LV remodeling and fibrosis may lead to diastolic dysfunction with greater susceptibility to worse clinical outcome in women.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Diastolic dysfunction; Hypertrophic cardiomyopathy; Sex

Mesh:

Substances:

Year:  2015        PMID: 26001434     DOI: 10.1016/j.ejrad.2015.04.026

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  8 in total

Review 1.  Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence.

Authors:  Yi Tan; Zhiguo Zhang; Chao Zheng; Kupper A Wintergerst; Bradley B Keller; Lu Cai
Journal:  Nat Rev Cardiol       Date:  2020-02-20       Impact factor: 32.419

Review 2.  Heart Failure With Preserved Ejection Fraction: A Review of Cardiac and Noncardiac Pathophysiology.

Authors:  Andreas B Gevaert; Jente R A Boen; Vincent F Segers; Emeline M Van Craenenbroeck
Journal:  Front Physiol       Date:  2019-05-29       Impact factor: 4.566

3.  Sex-Related Differences in Protein Expression in Sarcomere Mutation-Positive Hypertrophic Cardiomyopathy.

Authors:  Maike Schuldt; Larissa M Dorsch; Jaco C Knol; Thang V Pham; Tim Schelfhorst; Sander R Piersma; Cris Dos Remedios; Michelle Michels; Connie R Jimenez; Diederik W D Kuster; Jolanda van der Velden
Journal:  Front Cardiovasc Med       Date:  2021-03-01

4.  Preoperative myocardial fibrosis is associated with worse survival after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy: A delayed enhanced cardiac magnetic resonance study.

Authors:  Youzhou Chen; Xingshan Zhao; Jiansong Yuan; Yan Zhang; Wei Liu; Shubin Qiao
Journal:  Front Cardiovasc Med       Date:  2022-08-11

Review 5.  The Complex Relation between Atrial Cardiomyopathy and Thrombogenesis.

Authors:  Elisa D'Alessandro; Joris Winters; Frans A van Nieuwenhoven; Ulrich Schotten; Sander Verheule
Journal:  Cells       Date:  2022-09-22       Impact factor: 7.666

6.  Sex differences in the time course and mechanisms of vascular and cardiac aging in mice: role of the smooth muscle cell mineralocorticoid receptor.

Authors:  Jennifer J DuPont; Seung Kyum Kim; Rachel M Kenney; Iris Z Jaffe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-10-23       Impact factor: 4.733

7.  Maladaptive left ventricular remodeling in women: An analysis from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction study.

Authors:  Omeed Elboudwarej; Janet Wei; Navid Darouian; Galen Cook-Wiens; Quanlin Li; Louise E J Thomson; John W Petersen; R David Anderson; Puja Mehta; Chrisandra Shufelt; Daniel Berman; Babak Azarbal; Bruce Samuels; Eileen Handberg; George Sopko; Carl J Pepine; C Noel Bairey Merz
Journal:  Int J Cardiol       Date:  2018-10-01       Impact factor: 4.039

Review 8.  Diabetic Cardiomyopathy: Impact of Biological Sex on Disease Development and Molecular Signatures.

Authors:  Ryan Toedebusch; Anthony Belenchia; Lakshmi Pulakat
Journal:  Front Physiol       Date:  2018-05-03       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.